JP2008546640A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008546640A5 JP2008546640A5 JP2008511051A JP2008511051A JP2008546640A5 JP 2008546640 A5 JP2008546640 A5 JP 2008546640A5 JP 2008511051 A JP2008511051 A JP 2008511051A JP 2008511051 A JP2008511051 A JP 2008511051A JP 2008546640 A5 JP2008546640 A5 JP 2008546640A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- meta arsenite
- treatment
- sodium
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05076071.9 | 2005-05-09 | ||
| EP05076071A EP1721615A1 (en) | 2005-05-09 | 2005-05-09 | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
| PCT/KR2006/001731 WO2006121280A1 (en) | 2005-05-09 | 2006-05-09 | Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008546640A JP2008546640A (ja) | 2008-12-25 |
| JP2008546640A5 true JP2008546640A5 (https=) | 2012-06-14 |
| JP5026408B2 JP5026408B2 (ja) | 2012-09-12 |
Family
ID=35197739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008511051A Expired - Fee Related JP5026408B2 (ja) | 2005-05-09 | 2006-05-09 | 泌尿生殖器癌及びその転移の治療を意図した、亜ヒ酸、そのナトリウム塩、及びその誘導体を含む製薬組成物 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20090011047A1 (https=) |
| EP (5) | EP1721615A1 (https=) |
| JP (1) | JP5026408B2 (https=) |
| KR (3) | KR20160035101A (https=) |
| CN (2) | CN101277707A (https=) |
| AR (1) | AR054448A1 (https=) |
| AU (1) | AU2006244767B2 (https=) |
| BR (1) | BRPI0608716A2 (https=) |
| CA (3) | CA2840609C (https=) |
| CY (2) | CY1113475T1 (https=) |
| DK (2) | DK1885380T3 (https=) |
| ES (2) | ES2394264T3 (https=) |
| HU (1) | HUE046029T2 (https=) |
| IL (3) | IL187220A (https=) |
| LT (1) | LT3067068T (https=) |
| PL (2) | PL1885380T3 (https=) |
| PT (1) | PT1885380E (https=) |
| RU (1) | RU2401662C2 (https=) |
| SG (5) | SG177983A1 (https=) |
| SI (2) | SI3067068T1 (https=) |
| TW (5) | TWI386214B (https=) |
| WO (1) | WO2006121280A1 (https=) |
| ZA (1) | ZA200710559B (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1721615A1 (en) | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
| US8945505B2 (en) * | 2007-02-02 | 2015-02-03 | Panaphix, Inc. | Use of arsenic compounds for treatment of pain and inflammation |
| US20090246291A1 (en) | 2008-03-27 | 2009-10-01 | Angelika Burger | Method and compositions for treatment of cancer |
| US20120045520A1 (en) * | 2008-08-21 | 2012-02-23 | Sang Bong Lee | Pharmaceutical composition comprising arsenite for the treatment of malignancy |
| PT2475362T (pt) * | 2009-09-10 | 2019-05-27 | Kominox Inc | Terapia especifica para celulas estaminais cancerigenas e para 0 cancro resistente a medicamentos |
| BR112012008310A2 (pt) * | 2009-09-18 | 2017-06-06 | Kominox Inc | métodos para tratamento de tumores cerebrais |
| WO2011086137A1 (en) | 2010-01-13 | 2011-07-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Promyelocytic leukemia protein as a redox sensor |
| RU2602937C2 (ru) * | 2011-01-11 | 2016-11-20 | Универзитет Базель | Комбинация сиросингопина и митохондриальных ингибиторов для лечения рака и для иммуносупрессии |
| US20120251628A1 (en) * | 2011-03-30 | 2012-10-04 | Young Joo Min | Compositions and methods for treatment of cancer |
| KR101309844B1 (ko) * | 2013-03-15 | 2013-09-23 | 박상채 | 항암 활성 증진용 한약재 및 이의 제조방법 |
| RU2618405C1 (ru) * | 2015-12-31 | 2017-05-03 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Способ определения продолжительности адъювантной химиотерапии при местно-распространенном колоректальном раке с метастазами в регионарные лимфоузлы после радикальных оперативных вмешательств |
| US10806768B2 (en) * | 2016-05-26 | 2020-10-20 | Stephen N. Pitcher | Composition for promoting metallothionein production |
| ES2964979T3 (es) | 2016-12-01 | 2024-04-10 | Eupharma Pty Ltd | Composiciones de arsénico |
| EP3758686B1 (en) | 2018-02-26 | 2024-11-06 | R.P. Scherer Technologies, LLC | Pharmaceutical dosage form for an emulsion of simethicone and loperamide |
| AU2019239671B2 (en) * | 2018-03-22 | 2025-02-27 | Komipharm International Australia Pty Ltd | Pharmaceutical composition comprising meta arsenite and method of manufacture |
| WO2019234112A1 (en) * | 2018-06-05 | 2019-12-12 | Katholieke Universiteit Leuven | Combination treatment of arsenic oxide and antiandrogens |
| IL295648A (en) * | 2020-02-16 | 2022-10-01 | Komipharm Int Australia Pty Ltd | treatment method |
| KR20220020633A (ko) * | 2020-08-12 | 2022-02-21 | 이상봉 | 탈모방지 또는 발모촉진용 주사제 조성물 |
| KR20220020635A (ko) * | 2020-08-12 | 2022-02-21 | 이상봉 | 탈모방지 또는 발모촉진용 외용제 조성물 |
| KR20220020637A (ko) * | 2020-08-12 | 2022-02-21 | 이상봉 | 항암화학요법이나 방사선요법으로 인한 암 환자의 탈모증을 포함한 탈모증 환자에 대하여 탈모를 방지하고 발모를 촉진하는 메타아르세나이트의 염을 함유하는 경구 투여용 약학적 조성물 |
| CN112336746A (zh) * | 2020-10-23 | 2021-02-09 | 内蒙古科技大学包头医学院 | 一种膀胱癌灌注化疗药物及其应用 |
| CN116549741B (zh) * | 2022-01-29 | 2025-04-11 | 中国科学院上海硅酸盐研究所 | 一种具有抑癌抗菌作用的表面改性镍钛合金材料及其制备方法和应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| FR2431686A1 (fr) | 1978-07-20 | 1980-02-15 | Nestle Sa Soc Ass Tech Prod | Mecanisme de dosage et d'equilibrage et machine de remplissage comprenant un tel mecanisme |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| KR930001917A (ko) * | 1991-07-26 | 1993-02-22 | 김두석 | 악성 종양 치료제의 제조방법 |
| EP0804928B1 (en) * | 1994-02-18 | 2004-10-20 | Tamara Vasilievna Vorobieva | Agent having an immunomodulating effect and reducing disturbed functioning of the tissue cell propagation regulating system |
| RU2035181C1 (ru) * | 1994-02-18 | 1995-05-20 | Тамара Васильевна Воробьева | Средство для лечения лейкозов и способ лечения лейкозов |
| JP2001519366A (ja) * | 1997-10-15 | 2001-10-23 | ポーラクス バイオファーマシュティカルズ，インコーポレーテッド | ヒ素化合物を用いた、原発性および転移性の腫瘍性疾患を治療するための組成物および方法 |
| IL136051A0 (en) | 1997-11-10 | 2001-05-20 | Sloan Kettering Inst Cancer | Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| CN1233476A (zh) * | 1998-04-24 | 1999-11-03 | 陆道培 | 治疗急性白血病的药物及其制备方法 |
| KR20020083678A (ko) * | 2001-04-28 | 2002-11-04 | 주식회사 한국미생물연구소 | 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물 |
| TW200408407A (en) | 2001-11-30 | 2004-06-01 | Dana Farber Cancer Inst Inc | Methods and compositions for modulating the immune system and uses thereof |
| EP1496918B1 (en) * | 2002-04-10 | 2023-02-08 | Komipharm International Co., Ltd. | Use of sodium meta-arsenite for the treatment of tumours |
| KR100632250B1 (ko) * | 2004-02-16 | 2006-10-11 | 정태호 | 비소 화합물을 유효성분으로 하는 항암제 |
| US20060104292A1 (en) | 2004-11-15 | 2006-05-18 | Gupta Vivek G | System and methods for supporting multiple communications interfaces with single client interface |
| EP1721615A1 (en) | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
| US8945505B2 (en) | 2007-02-02 | 2015-02-03 | Panaphix, Inc. | Use of arsenic compounds for treatment of pain and inflammation |
| US20090246291A1 (en) | 2008-03-27 | 2009-10-01 | Angelika Burger | Method and compositions for treatment of cancer |
| PT2475362T (pt) | 2009-09-10 | 2019-05-27 | Kominox Inc | Terapia especifica para celulas estaminais cancerigenas e para 0 cancro resistente a medicamentos |
-
2005
- 2005-05-09 EP EP05076071A patent/EP1721615A1/en not_active Withdrawn
-
2006
- 2006-05-09 SG SG2012003091A patent/SG177983A1/en unknown
- 2006-05-09 AR ARP060101851A patent/AR054448A1/es unknown
- 2006-05-09 SI SI200632358T patent/SI3067068T1/sl unknown
- 2006-05-09 CN CNA2006800250320A patent/CN101277707A/zh active Pending
- 2006-05-09 AU AU2006244767A patent/AU2006244767B2/en not_active Ceased
- 2006-05-09 PT PT06732912T patent/PT1885380E/pt unknown
- 2006-05-09 LT LT16162414T patent/LT3067068T/lt unknown
- 2006-05-09 KR KR1020167007395A patent/KR20160035101A/ko not_active Ceased
- 2006-05-09 US US11/631,962 patent/US20090011047A1/en not_active Abandoned
- 2006-05-09 TW TW095116432A patent/TWI386214B/zh not_active IP Right Cessation
- 2006-05-09 SI SI200631444T patent/SI1885380T1/sl unknown
- 2006-05-09 CA CA2840609A patent/CA2840609C/en active Active
- 2006-05-09 TW TW103132530A patent/TWI522105B/zh not_active IP Right Cessation
- 2006-05-09 KR KR1020157017831A patent/KR20150085122A/ko not_active Ceased
- 2006-05-09 TW TW104124162A patent/TWI574692B/zh not_active IP Right Cessation
- 2006-05-09 DK DK06732912.8T patent/DK1885380T3/da active
- 2006-05-09 SG SG10201405278SA patent/SG10201405278SA/en unknown
- 2006-05-09 CA CA2608035A patent/CA2608035C/en active Active
- 2006-05-09 BR BRPI0608716-7A patent/BRPI0608716A2/pt not_active Application Discontinuation
- 2006-05-09 ES ES06732912T patent/ES2394264T3/es active Active
- 2006-05-09 EP EP06732912A patent/EP1885380B1/en active Active
- 2006-05-09 TW TW105102103A patent/TW201615200A/zh unknown
- 2006-05-09 KR KR1020077028751A patent/KR101413731B1/ko not_active Expired - Fee Related
- 2006-05-09 EP EP11165670.8A patent/EP2361628A1/en not_active Ceased
- 2006-05-09 CN CN201510064962.8A patent/CN104758312A/zh active Pending
- 2006-05-09 EP EP16162414.3A patent/EP3067068B1/en active Active
- 2006-05-09 SG SG10201602555WA patent/SG10201602555WA/en unknown
- 2006-05-09 HU HUE16162414A patent/HUE046029T2/hu unknown
- 2006-05-09 SG SG2011075330A patent/SG175633A1/en unknown
- 2006-05-09 PL PL06732912T patent/PL1885380T3/pl unknown
- 2006-05-09 DK DK16162414T patent/DK3067068T3/da active
- 2006-05-09 JP JP2008511051A patent/JP5026408B2/ja not_active Expired - Fee Related
- 2006-05-09 ES ES16162414T patent/ES2754372T3/es active Active
- 2006-05-09 TW TW101132058A patent/TWI539957B/zh active
- 2006-05-09 WO PCT/KR2006/001731 patent/WO2006121280A1/en not_active Ceased
- 2006-05-09 RU RU2007145489/14A patent/RU2401662C2/ru active
- 2006-05-09 EP EP14166070.4A patent/EP2762145A1/en not_active Ceased
- 2006-05-09 CA CA2926846A patent/CA2926846C/en active Active
- 2006-05-09 PL PL16162414T patent/PL3067068T3/pl unknown
- 2006-05-09 SG SG10202100785PA patent/SG10202100785PA/en unknown
-
2007
- 2007-11-07 IL IL187220A patent/IL187220A/en active IP Right Grant
- 2007-12-04 ZA ZA200710559A patent/ZA200710559B/xx unknown
-
2012
- 2012-10-10 CY CY20121100940T patent/CY1113475T1/el unknown
-
2013
- 2013-12-17 IL IL229975A patent/IL229975A/en active IP Right Grant
-
2016
- 2016-03-22 US US15/077,373 patent/US11464859B2/en active Active
- 2016-03-22 IL IL244728A patent/IL244728A0/en unknown
-
2019
- 2019-11-06 CY CY20191101162T patent/CY1122522T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008546640A5 (https=) | ||
| Roviello et al. | Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments | |
| JP2020519672A5 (https=) | ||
| JP2011501962A5 (https=) | ||
| Fu et al. | Cell cycle arrest and induction of apoptosis by cajanin stilbene acid from Cajanus cajan in breast cancer cells | |
| Politi et al. | Epithelial-myoepithelial carcinoma of the parotid gland: Clinicopathological aspect, diagnosis and surgical consideration | |
| JP2021520349A5 (https=) | ||
| JP2013544892A5 (https=) | ||
| Akgun et al. | Estrogen receptor-beta is expressed in Barrett's metaplasia and associated adenocarcinoma of the esophagus | |
| RU2015156221A (ru) | Фармацевтические комбинация ингибитора pi3k и средства, дестабилизирующего микротрубочки | |
| Terada | Protein expression and gene mutation status of KIT and PDGFRA in renal cell carcinoma | |
| Shong-San et al. | Adenoid cystic carcinoma of prostate report of a case | |
| JPWO2022170974A5 (https=) | ||
| CA2656005A1 (en) | Chemotherapeutic compounds for selectively targeting tumor cells with fr type receptors | |
| Barua et al. | Correlation of epidermal growth factor receptor score with prognostic variables in transitional cell carcinoma of urinary bladder among northeastern Indian population | |
| JP2005513000A5 (https=) | ||
| Costa-Pereira et al. | Molecular and cellular biology of prostate cancer—the role of apoptosis as a target for therapy | |
| Fan | Feline mammary tumors: current and future therapies. | |
| Matsika et al. | Epithelioid haemangioendothelioma of the uterine cervix with CAMTA1/WWTR1 translocation | |
| Mabille et al. | CT in the follow-up of advanced gastro-intestinal stromal tumors (GIST) under treatment by Imatinib Mesylate (Gleevec®): New criteria of evaluation | |
| Ke-Chun et al. | The role of SPDEF in cancer: promoter or suppressor. | |
| Lai et al. | Benign metastasizing ameloblastoma or malignant ameloblastoma? | |
| Leung et al. | Ductal type signet ring cell carcinoma of breast with growth pattern of pure mucinous carcinoma | |
| De Meulenaere et al. | Prolonged survival in a nasopharyngeal carcinoma (NPC) patient with metastatic disease: a case report | |
| Tural et al. | Kakizoe, T. Jpn J Clin Oncol 2013 43: 1 |